29Aug/13

Novel Approach to Amyloidosis Looks Promising – MedPage Today

Novel Approach to Amyloidosis Looks Promising
MedPage Today
“The ability of [the second-generation drug] to lower both mutant and nonmutant proteins may also provide a major advantage over liver transplantation, which affects the production of only mutant protein.” Though it was a phase I, proof-of-principle
Alnylam and Collaborators Publish Clinical Trial Results with RNAi DailyFinance

all 4 news articles »